The percentage of adolescents 13 years of age who had one dose of meningococcal vaccine, one tetanus, diphtheria toxoids and acellular pertussis (Tdap) vaccine, and have completed the human papillomavirus (HPV) vaccine series by their 13th birthday.
Adolescents who received all the following (each row) within the specified time frames (see notes section).
Compliance can be met with any of the listed criteria for each vaccine in the below table (i.e. patient received the vaccine or has a history of the vaccine causing anaphylaxis or encephalitis).
Vaccine | Doses | Combo vaccine or antigen | Anaphylaxis r/t vaccine | Encephalitis r/t vaccine | |
MCV | Meningococcal | 1 | X | X | N/A |
Tdap | Tetanus, diphtheria toxoids and acellular pertussis | 1 | X | X | X |
HPV | Human papilloma virus | 2-3 | X | X | N/A |
Providers and organizations must submit accurate and complete data in accordance with all billing, coding, and medical policy requirements. HEDIS guidance does not override official coding standards or guarantee reimbursement, as coverage is subject to applicable medical/coding policy and member-specific benefits.
Should you have specific coding or other questions related to the measure, please send your questions to BlueAlliance@bcbsnd.com.
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
Updated 8/28/2026